OUR PLATFORM | APPLICATIONS

Architects of Wound Care

Designed to restore the biological foundation that closure depends on.
When trauma, burns or surgery destroy the extracellular matrix (ECM) scaffold, the challenge is not only to close the wound, but to restore the structural quality and function of the original tissue. Current treatments often fall short, failing to achieve the conforming coverage and tissue integration complex wounds require.
This is the unmet need CXU is poised to address.

Overview

Engineered to mimic the body’s natural extracellular matrix, our collagen-based ECM is designed to create a more complete structural environment than collagen alone.

The temperature-sensitive CXU formulation gels in place within approximately 10 minutes, conforming to complex wound geometry and filling irregular spaces. In doing so, it is designed to support cell infiltration and vascular ingrowth for more organized healing. The result is a stable, 3D structure intended to support new functional tissue formation across the wound.

CAUTION: CXU™ is a medical device candidate in preclinical development and is not cleared or approved for marketing in the United States or any other jurisdiction.

How CXU Works

How it works

The CXU formula creates a permissive and adaptive extracellular matrix environment, designed to conform, integrate and regenerate.9,3,6

Conform
  • Flows into irregular spaces
  • Maintains close tissue contact
  • Adapts to local tissue architecture
Integrate
  • Gels near body temperature
  • Forms within approximately 10 minutes
  • Stays in place without migration
Regenerate
  • Designed to support tissue restoration and to mimic tissue ECM
  • Intended to support durable closure and regeneration with less scarring
CAUTION: CXU™ is a medical device candidate in preclinical development and is not cleared or approved for marketing in the United States or any other jurisdiction.

Key Features

When tissue is destroyed by trauma, burns or surgery, CXU is designed to provide these benefits.*

Collagen-ECM Scaffold

Designed to more closely mimic the complexity of the body’s natural extracellular matrix, offering a more complete structurally supportive environment than collagen alone.

Tissue Integration

Engineered to conform and support a faster path to closure, with potential to reduce time in advanced wound therapy.

Better Outcomes

Designed to potentially lower complication and risk associated with incomplete closures and non-integrated interfaces.

*Design intent based on preclinical evidence. These findings were generated in controlled laboratory settings and animal models. Animal physiology differs from human physiology and these findings may not be predictive of clinical performance or safety in humans. Clinical significance not yet established.

Explore Other Applications

IMPORTANT NOTICES: CXU™ is a medical device candidate in preclinical development. It has not been submitted to or reviewed by the U.S. Food and Drug Administration. Safety and effectiveness have not been established. See Forward-Looking Cautionary Statement.Terms such as 'next-generation,' 'advanced,' 'innovative,' and 'bioregenerative' reflect the Company's assessment of its technology relative to existing approaches and are not intended as representations of regulatory status, clinical performance, or guaranteed commercial outcomes. CXU™ is an investigational medical device candidate. Safety and effectiveness have not been established. See Forward-Looking Cautionary Statement.
Close

Error Displaying Name

Error Displaying Title